Business
Pfizer’s COVID-19 vaccine found to be highly effective for adolescents – ABC News
A study of the Pfizer vaccine shows the jab is highly effective in adolescents aged 12-15 years old, recording higher levels of antibodies than in young adults.
Pfizer and BioNTech’s COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, according to a trial run by the companies.
Key points:
- No cases were detected in the trial group who got the vaccine, compared with 18 in the placebo group
- The trial participants experienced the same side-effects that had been noted in adults
- Pfizer hopes to begin vaccinating US teenagers before the new school year
The data from a clinical trial, which puts the shot ahead of other…
-
Noosa News9 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
General15 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News16 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
Noosa News16 hours agoDetectives continue to search for answers on Crystal Beale’s death